Internal Medicine, Endocrinology, Diabetes, & Metabolism · Livingston, NJ
NPI
1942260690
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 S Orange Ave, Suite 219
Livingston, NJ, 07039
Phone (973) 322-7200
Groups this clinician bills Medicare through
Medicare paid, 2024
$546K
32,850 services
Medicare patients, 2024
953
Average age 78
Drug cost, 2024
$3.1M
9,847 prescriptions
Company payments, 2025
$17.86
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel Dower was code 99214 (office e&m - established), 1,327 times for 819 patients. In total Samuel Dower billed 32,850 services in 55 codes, and Medicare paid $546K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,327 | 819 | $97.62 | $130K |
| 36415 Venipuncture Blood Collection | Office | 1,142 | 615 | $2.94 | $3,357 |
| 84443 Clinical Chemistry | Office | 1,095 | 606 | $16.46 | $18K |
| 84439 Clinical Chemistry | Office | 1,061 | 585 | $8.84 | $9,379 |
| 84481 Clinical Chemistry | Office | 1,060 | 584 | $16.60 | $18K |
| 80053 Clinical Chemistry | Office | 1,057 | 565 | $10.35 | $11K |
| 83970 Clinical Chemistry | Office | 1,055 | 548 | $40.45 | $43K |
| 86376 Immunoassay | Office | 1,049 | 579 | $14.26 | $15K |
| 82977 Clinical Chemistry | Office | 1,046 | 567 | $7.06 | $7,385 |
| 84100 Clinical Chemistry | Office | 1,045 | 565 | $4.65 | $4,859 |
| 83735 Clinical Chemistry | Office | 1,044 | 565 | $6.57 | $6,859 |
| 84550 Clinical Chemistry | Office | 1,044 | 565 | $4.43 | $4,625 |
| 86800 Immunoassay | Office | 1,044 | 578 | $15.59 | $16K |
| 82610 Clinical Chemistry | Office | 1,042 | 563 | $18.15 | $19K |
| 85025 Blood Count | Office | 1,038 | 561 | $7.61 | $7,899 |
By year: 2022 $509K for 32,926 services; 2023 $531K for 33,194 services; 2024 $546K for 32,850 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,142 | 615 | $2.94 | $3,357 |
| 84443 Clinical Chemistry | 1,095 | 606 | $16.46 | $18K |
| 84439 Clinical Chemistry | 1,061 | 585 | $8.84 | $9,379 |
| 84481 Clinical Chemistry | 1,060 | 584 | $16.60 | $18K |
| 80053 Clinical Chemistry | 1,057 | 565 | $10.35 | $11K |
| 83970 Clinical Chemistry | 1,055 | 548 | $40.45 | $43K |
| 86376 Immunoassay | 1,049 | 579 | $14.26 | $15K |
| 82977 Clinical Chemistry | 1,046 | 567 | $7.06 | $7,385 |
| 84100 Clinical Chemistry | 1,045 | 565 | $4.65 | $4,859 |
| 83735 Clinical Chemistry | 1,044 | 565 | $6.57 | $6,859 |
Medicare prescription drug claims, 2024
In 2024, the drug Samuel Dower prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,338 prescriptions and refills. In total Samuel Dower wrote 9,847 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,338 | 3,775 | 364 | $19K |
| Synthroid Levothyroxine Sodium | 598 | 1,655 | 157 | $63K |
| Metformin Hcl Er Metformin Hcl | 513 | 1,421 | 156 | $8,886 |
| Ozempic Semaglutide | 374 | 640 | 79 | $566K |
| Metformin Hcl Generic | 356 | 1,014 | 110 | $4,603 |
| Atorvastatin Calcium Generic | 325 | 933 | 97 | $3,346 |
| Glimepiride Generic | 299 | 873 | 90 | $4,267 |
| Rosuvastatin Calcium Generic | 281 | 798 | 79 | $4,234 |
| Mounjaro Tirzepatide | 261 | 357 | 43 | $372K |
| Glipizide Er Glipizide | 215 | 602 | 60 | $4,767 |
| Jardiance Empagliflozin | 198 | 476 | 43 | $270K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 166 | 390 | 68 | $19K |
| Farxiga Dapagliflozin Propanediol | 164 | 346 | 34 | $187K |
| Tradjenta Linagliptin | 138 | 321 | 31 | $155K |
| Janumet Sitagliptin Phos/Metformin Hcl | 131 | 313 | 32 | $152K |
Brand drugs: 3,841 claims; generic drugs: 5,435 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel Dower $17.86 ($17.86 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $17.86.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $17.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.